Growth hormone deficiency drug from OPKO and Pfizer fails study

Dec 30 (Reuters) - OPKO Health Inc said on Friday

its experimental drug for growth hormone deficiency did not

provide a statistically significant benefit over a placebo in a

late-stage study.

Read more